AIM ImmunoTech Inc. (AIMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0400
+0.0100 (33.33%)
Apr 17, 2025, 4:00 PM EDT
AIM ImmunoTech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -17.32 | -28.96 | -19.45 | -19.13 | -14.4 | Upgrade
|
| Depreciation & Amortization | 0.25 | 0.24 | 0.26 | 0.78 | 0.73 | Upgrade
|
| Other Amortization | 0.3 | - | - | 0.05 | 0.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.02 | - | -0.22 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.05 | 0.01 | - | 1.78 | 0.29 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.09 | -0.2 | 1.68 | 0.05 | - | Upgrade
|
| Stock-Based Compensation | 0.69 | 0.24 | 0.95 | 1.57 | 1.04 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | -0.03 | Upgrade
|
| Other Operating Activities | 0.76 | 0.29 | -0.52 | 0.27 | 1.28 | Upgrade
|
| Change in Accounts Receivable | - | - | - | 0.03 | 0.04 | Upgrade
|
| Change in Accounts Payable | -0.06 | 6.07 | 0.18 | -0.19 | -0.09 | Upgrade
|
| Change in Other Net Operating Assets | 0.36 | 1.07 | 0.79 | 1.05 | 0.65 | Upgrade
|
| Operating Cash Flow | -14.89 | -21.27 | -16.11 | -13.97 | -10.37 | Upgrade
|
| Capital Expenditures | -0.02 | - | -0.09 | -0.04 | -0.02 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.05 | 3.9 | 0.25 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.54 | -0.59 | -0.19 | -0.59 | -0.57 | Upgrade
|
| Investment in Securities | 5.26 | -0.29 | 7.36 | -0.24 | -8.57 | Upgrade
|
| Investing Cash Flow | 4.71 | -0.83 | 10.99 | -0.63 | -9.16 | Upgrade
|
| Long-Term Debt Issued | 2.5 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.25 | - | - | -4.85 | -4.69 | Upgrade
|
| Net Debt Issued (Repaid) | 2.25 | - | - | -4.85 | -4.69 | Upgrade
|
| Issuance of Common Stock | 0.89 | 0.49 | 0.08 | 13.04 | 61.25 | Upgrade
|
| Other Financing Activities | 3.3 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 6.44 | 0.49 | 0.08 | 8.19 | 56.56 | Upgrade
|
| Net Cash Flow | -3.74 | -21.61 | -5.04 | -6.41 | 37.03 | Upgrade
|
| Free Cash Flow | -14.91 | -21.27 | -16.19 | -14.01 | -10.39 | Upgrade
|
| Free Cash Flow Margin | -8768.24% | -10528.22% | -11485.11% | -10374.81% | -6374.23% | Upgrade
|
| Free Cash Flow Per Share | -0.27 | -0.44 | -0.34 | -0.30 | -0.33 | Upgrade
|
| Levered Free Cash Flow | -12.2 | -12.16 | -11.15 | -9.77 | -8.11 | Upgrade
|
| Unlevered Free Cash Flow | -12.13 | -12.16 | -11.15 | -9.78 | -7.8 | Upgrade
|
| Change in Net Working Capital | 0.15 | -7.89 | -0.36 | 0.83 | -0.31 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.